Literature DB >> 32133541

Whey milk proteomics from Schistosoma mansoni-infected mice reveals proteins involved in immunomodulation of the offspring.

Gabriela Calixto Ribeiro de Holanda1, Iasmim Lopes de Lima1, Sandra Mara Naressi Scapin2, Maria da Conceição Silva1, Iana Rafaela Fernandes Sales3, José Mauro Granjeiro2, Roberto Afonso da Silva1, Valdenia Maria Oliveira de Souza4, José Luiz de Lima Filho1.   

Abstract

Milk from schistosomotic mothers can modulate the immune response of their offspring. However, its characterization and potential of modulating immunity has not yet been fully elucidated. Thus, the aim of this study was to evaluate whey proteins from the milk of Schistosoma mansoni-infected mice in order to identify the fractions which can act as potential immunomodulatory tools. For this, we did a mass spectrometry (nanoUPLC-MSE) analysis to characterize the proteomic profile of milk from infected (MIM) and non-infected mice (MNIM). It was possible to identify 29 differentially expressed proteins: 15 were only found in MIM, 10 only found in MNIM, and 4 were downregulated in MIM group. Gene Ontology (GO), pathway enrichment analysis, and protein-protein interaction (PPI) analyses indicated differentially expressed proteins linked to biological processes and pathways in MIM group such as the following: fructose 1,6-biphosphate metabolic and glycolytic processes, glucose metabolism, and neutrophil degranulation pathways. The downregulated and unique proteins identified in MNIM group were involved in the positive regulation of B cell activation and receptor signaling pathway, in the innate immune response, complement activation, and phagocytosis. The present findings revealed a protein profile that may be involved in the activation and deactivation of the offspring's immune system in the long term, conferring a protective character due to the previous contact with milk from infected mothers.

Entities:  

Keywords:  Breastfeeding; Immune response; Mass spectrometry; Offspring; Proteomics; Schistosomiasis

Mesh:

Substances:

Year:  2020        PMID: 32133541     DOI: 10.1007/s00436-020-06643-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  48 in total

1.  The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.

Authors:  Gaynor J Bates; Samantha M Nicol; Brian J Wilson; Anne-Marie F Jacobs; Jean-Christophe Bourdon; Julie Wardrop; David J Gregory; David P Lane; Neil D Perkins; Frances V Fuller-Pace
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

2.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni.

Authors:  N Katz; A Chaves; J Pellegrino
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1972 Nov-Dec       Impact factor: 1.846

3.  Maternal immune response to helminth infection during pregnancy determines offspring susceptibility to allergic airway inflammation.

Authors:  Kathrin Straubinger; Sabine Paul; Olivia Prazeres da Costa; Manuel Ritter; Thorsten Buch; Dirk H Busch; Laura E Layland; Clarissa U Prazeres da Costa
Journal:  J Allergy Clin Immunol       Date:  2014-07-18       Impact factor: 10.793

4.  Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.

Authors:  Ryan D Michalek; Valerie A Gerriets; Sarah R Jacobs; Andrew N Macintyre; Nancie J MacIver; Emily F Mason; Sarah A Sullivan; Amanda G Nichols; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

5.  Influence of maternal schistosomiasis on the immunity of adult offspring mice.

Authors:  Patrícia d'Emery Alves Santos; Iana Rafaela Fernandes Sales; Giuliana Viegas Schirato; Vlaudia Maria Assis Costa; Mônica Camelo P A Albuquerque; Valdênia Maria Oliveira Souza; Elizabeth Malagueño
Journal:  Parasitol Res       Date:  2010-04-07       Impact factor: 2.289

6.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  Differentiation, maturation, and survival of dendritic cells by osteopontin regulation.

Authors:  Kodai Kawamura; Kazuhiro Iyonaga; Hidenori Ichiyasu; Junji Nagano; Moritaka Suga; Yutaka Sasaki
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

8.  Placental and oral delivery of Schistosoma mansoni antigen from infected mothers to their newborns and children.

Authors:  Abdelfattah M Attallah; Gamal E Ghanem; Hisham Ismail; Ahmed M El Waseef
Journal:  Am J Trop Med Hyg       Date:  2003-06       Impact factor: 2.345

9.  Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis.

Authors:  B Tong; B Wan; Z Wei; T Wang; P Zhao; Y Dou; Z Lv; Y Xia; Y Dai
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

10.  Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.

Authors:  Shirin Elhaik Goldman; Shahar Dotan; Amir Talias; Amit Lilo; Shalhevet Azriel; Itay Malka; Maxim Portnoi; Ariel Ohayon; Daniel Kafka; Ronald Ellis; Moshe Elkabets; Angel Porgador; Ditza Levin; Rosa Azhari; Edwin Swiatlo; Eduard Ling; Galia Feldman; Michael Tal; Ron Dagan; Yaffa Mizrachi Nebenzahl
Journal:  Int J Mol Med       Date:  2016-03-01       Impact factor: 4.101

View more
  1 in total

1.  Suckling by Schistosoma mansoni-infected mothers restored IgG2a and TGF-β production, but not IL-6 and delayed-type hypersensitivity in IL-12/IL-23-deficient mice.

Authors:  Fabiana Leticia da Silva; Maria da Conceição Silva; Gabriela Calixto Ribeiro de Holanda; Eridan de Medeiros Coutinho; Silvia Maria Lucena Montenegro; Clarice Neuenschwander Lins de Morais; Valdênia Maria Oliveira de Souza
Journal:  Rev Soc Bras Med Trop       Date:  2021-03-22       Impact factor: 1.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.